These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 16165218)

  • 21. Expression of the angiogenic factors vascular endothelial cell growth factor, acidic and basic fibroblast growth factor, tumor growth factor beta-1, platelet-derived endothelial cell growth factor, placenta growth factor, and pleiotrophin in human primary breast cancer and its relation to angiogenesis.
    Relf M; LeJeune S; Scott PA; Fox S; Smith K; Leek R; Moghaddam A; Whitehouse R; Bicknell R; Harris AL
    Cancer Res; 1997 Mar; 57(5):963-9. PubMed ID: 9041202
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The relationship between microvessel density, proliferative activity and expression of vascular endothelial growth factor-A and its receptors in eutopic endometrium and endometriotic lesions.
    Bourlev V; Volkov N; Pavlovitch S; Lets N; Larsson A; Olovsson M
    Reproduction; 2006 Sep; 132(3):501-9. PubMed ID: 16940291
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Endoglin: An accessory component of the TGF-beta-binding receptor-complex with diagnostic, prognostic, and bioimmunotherapeutic potential in human malignancies.
    Fonsatti E; Del Vecchio L; Altomonte M; Sigalotti L; Nicotra MR; Coral S; Natali PG; Maio M
    J Cell Physiol; 2001 Jul; 188(1):1-7. PubMed ID: 11382917
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular characterization and in situ localization of murine endoglin reveal that it is a transforming growth factor-beta binding protein of endothelial and stromal cells.
    St-Jacques S; Cymerman U; Pece N; Letarte M
    Endocrinology; 1994 Jun; 134(6):2645-57. PubMed ID: 8194490
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pregnancy affects morphology of induced endometriotic lesions in a mouse model through alteration of proliferation and angiogenesis.
    Cohen J; Naoura I; Castela M; Von N'Guyen T; Oster M; Fontaine R; Chabbert-Buffet N; Darai E; Aractingi S
    Eur J Obstet Gynecol Reprod Biol; 2014 Dec; 183():70-7. PubMed ID: 25461356
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Over-expression of endoglin (CD105): a marker of breast carcinoma-induced neo-vascularization.
    Bodey B; Bodey B; Siegel SE; Kaiser HE
    Anticancer Res; 1998; 18(5A):3621-8. PubMed ID: 9858949
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vascular endothelial growth factor induces abnormal microvasculature in the endoglin heterozygous mouse brain.
    Xu B; Wu YQ; Huey M; Arthur HM; Marchuk DA; Hashimoto T; Young WL; Yang GY
    J Cereb Blood Flow Metab; 2004 Feb; 24(2):237-44. PubMed ID: 14747750
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Endoglin in angiogenesis and vascular diseases.
    ten Dijke P; Goumans MJ; Pardali E
    Angiogenesis; 2008; 11(1):79-89. PubMed ID: 18283546
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression pattern of fibroblast growth factors (FGFs), their receptors and antagonists in primary endothelial cells and vascular smooth muscle cells.
    Antoine M; Wirz W; Tag CG; Mavituna M; Emans N; Korff T; Stoldt V; Gressner AM; Kiefer P
    Growth Factors; 2005 Jun; 23(2):87-95. PubMed ID: 16019430
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Defective angiogenesis in mice lacking endoglin.
    Li DY; Sorensen LK; Brooke BS; Urness LD; Davis EC; Taylor DG; Boak BB; Wendel DP
    Science; 1999 May; 284(5419):1534-7. PubMed ID: 10348742
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of TGF-beta1 in smooth muscle cells regulates endothelial progenitor cells migration and differentiation.
    Zhu C; Ying D; Zhou D; Mi J; Zhang W; Chang Q; Li L
    J Surg Res; 2005 May; 125(2):151-6. PubMed ID: 15854667
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunocytochemical detection of endoglin is indicative of angiogenesis in malignant melanoma.
    Bodey B; Bodey B; Siegel SE; Kaiser HE
    Anticancer Res; 1998; 18(4A):2701-10. PubMed ID: 9703932
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Endoglin-mediated vascular remodeling: mechanisms underlying hereditary hemorrhagic telangiectasia.
    Lebrin F; Mummery CL
    Trends Cardiovasc Med; 2008 Jan; 18(1):25-32. PubMed ID: 18206806
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of dual specificity phosphatase-2 by hypoxia promotes interleukin-8-mediated angiogenesis in endometriosis.
    Hsiao KY; Chang N; Lin SC; Li YH; Wu MH
    Hum Reprod; 2014 Dec; 29(12):2747-55. PubMed ID: 25316445
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Endoglin for tumor imaging and targeted cancer therapy.
    Paauwe M; ten Dijke P; Hawinkels LJ
    Expert Opin Ther Targets; 2013 Apr; 17(4):421-35. PubMed ID: 23327677
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Imaging of tumour neovasculature by targeting the TGF-beta binding receptor endoglin.
    Bredow S; Lewin M; Hofmann B; Marecos E; Weissleder R
    Eur J Cancer; 2000 Mar; 36(5):675-81. PubMed ID: 10738134
    [TBL] [Abstract][Full Text] [Related]  

  • 37. BMP-9 signals via ALK1 and inhibits bFGF-induced endothelial cell proliferation and VEGF-stimulated angiogenesis.
    Scharpfenecker M; van Dinther M; Liu Z; van Bezooijen RL; Zhao Q; Pukac L; Löwik CW; ten Dijke P
    J Cell Sci; 2007 Mar; 120(Pt 6):964-72. PubMed ID: 17311849
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Targeting tumor micro-environment for design and development of novel anti-angiogenic agents arresting tumor growth.
    Gacche RN; Meshram RJ
    Prog Biophys Mol Biol; 2013 Nov; 113(2):333-54. PubMed ID: 24139944
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Endoglin (CD105)--a target for visualization and anti-angiogenic therapy for malignant tumors].
    Smirnov IV; Gryazeva IV; Samoilovich MP; Klimovich VB
    Vopr Onkol; 2015; 61(6):898-907. PubMed ID: 26995976
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular pathways: can activin-like kinase pathway inhibition enhance the limited efficacy of VEGF inhibitors?
    Bhatt RS; Atkins MB
    Clin Cancer Res; 2014 Jun; 20(11):2838-45. PubMed ID: 24714770
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.